329 related articles for article (PubMed ID: 35118583)
21. Establishment and characterization of NCC-SS4-C1: a novel patient-derived cell line of synovial sarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Ono T; Sei A; Takeshita F; Sugaya J; Iwata S; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 May; 34(3):998-1007. PubMed ID: 33611700
[TBL] [Abstract][Full Text] [Related]
22. Establishment and characterization of NCC-SS5-C1: a novel patient-derived cell line of synovial sarcoma.
Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Akiyama T; Sugaya J; Kojima N; Yoshida A; Kawai A; Kondo T
Hum Cell; 2022 Jul; 35(4):1290-1297. PubMed ID: 35655041
[TBL] [Abstract][Full Text] [Related]
23. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1.
Adachi Y; Noguchi R; Yoshimatsu Y; Sin Y; Osaki J; Ono T; Iwata S; Akiyama T; Tsuchiya R; Toda Y; Ishihara S; Ogura K; Kobayashi E; Kojima N; Yoshida A; Yokoo H; Kawai A; Kondo T
Hum Cell; 2024 May; 37(3):874-885. PubMed ID: 38466561
[TBL] [Abstract][Full Text] [Related]
24. Establishment and characterization of NCC-MFS4-C1: a novel patient-derived cell line of myxofibrosarcoma.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Sin Y; Ono T; Sugaya J; Iwata S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2021 Nov; 34(6):1911-1918. PubMed ID: 34383271
[TBL] [Abstract][Full Text] [Related]
25. Establishment and characterization of NCC-DDLPS1-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sei A; Takeshita F; Sugaya J; Fukushima S; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 Jan; 34(1):260-270. PubMed ID: 32949334
[TBL] [Abstract][Full Text] [Related]
26. Establishment and characterization of NCC-DFSP3-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Nakagawa M; Yoshida A; Kawai A; Kondo T
Hum Cell; 2020 Jul; 33(3):894-903. PubMed ID: 32356243
[TBL] [Abstract][Full Text] [Related]
27. Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome.
Le AN; Harton J; Desai H; Powers J; Zelley K; Bradbury AR; Nathanson KL; Shah PD; Doucette A; Freedman GM; Gabriel P; Domchek SM; MacFarland SP; Maxwell KN
Breast Cancer Res Treat; 2020 May; 181(1):181-188. PubMed ID: 32246378
[TBL] [Abstract][Full Text] [Related]
28. The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations.
Silva AG; Krepischi AC; Pearson PL; Hainaut P; Rosenberg C; Achatz MI
Orphanet J Rare Dis; 2014 Apr; 9():63. PubMed ID: 24775443
[TBL] [Abstract][Full Text] [Related]
29. Establishment and characterization of a novel patient-derived cell line of dedifferentiated liposarcoma, NCC-DDLPS6-C1.
Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Akiyama T; Nakagawa R; Kamio S; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2022 Jul; 35(4):1270-1278. PubMed ID: 35604485
[TBL] [Abstract][Full Text] [Related]
30. Establishment and characterization of a novel patient-derived Ewing sarcoma cell line, NCC-ES2-C1.
Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Akiyama T; Nakagawa R; Kamio S; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2022 Jul; 35(4):1262-1269. PubMed ID: 35441357
[TBL] [Abstract][Full Text] [Related]
31. Establishment and characterization of NCC-MRT1-C1: a novel cell line of malignant rhabdoid tumor.
Akiyama T; Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Sato C; Kojima N; Yoshida A; Kawai A; Ohtori S; Kondo T
Hum Cell; 2022 Nov; 35(6):2002-2010. PubMed ID: 35927606
[TBL] [Abstract][Full Text] [Related]
32. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.
Sugawara W; Arai Y; Kasai F; Fujiwara Y; Haruta M; Hosaka R; Nishida K; Kurosumi M; Kobayashi Y; Akagi K; Kaneko Y
Genes Chromosomes Cancer; 2011 Jul; 50(7):535-45. PubMed ID: 21484931
[TBL] [Abstract][Full Text] [Related]
33. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH
Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745
[TBL] [Abstract][Full Text] [Related]
34. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
[TBL] [Abstract][Full Text] [Related]
35. Establishment and characterization of NCC-DDLPS5-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.
Sin Y; Yoshimatsu Y; Noguchi R; Tsuchiya R; Ono T; Akiyama T; Iwata S; Sugaya J; Yoshida A; Kawai A; Kondo T
Hum Cell; 2022 May; 35(3):936-943. PubMed ID: 35292923
[TBL] [Abstract][Full Text] [Related]
36. Establishment and characterization of NCC-MFS6-C1: a novel patient-derived cell line of myxofibrosarcoma.
Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Akiyama T; Sato C; Kobayashi E; Kojima N; Yoshida A; Kawai A; Kondo T
Hum Cell; 2022 Nov; 35(6):1993-2001. PubMed ID: 35947340
[TBL] [Abstract][Full Text] [Related]
37. Establishment and characterization of novel patient-derived cell lines from giant cell tumor of bone.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Ono T; Sin Y; Akane S; Sugaya J; Mori T; Fukushima S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2021 Nov; 34(6):1899-1910. PubMed ID: 34304386
[TBL] [Abstract][Full Text] [Related]
38. Establishment and characterization of NCC-LGFMS1-C1: a novel patient-derived cell line of low-grade fibromyxoid sarcoma.
Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Sei A; Sugaya J; Iwata S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2021 Nov; 34(6):1919-1928. PubMed ID: 34535876
[TBL] [Abstract][Full Text] [Related]
39. Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1.
Oyama R; Kito F; Qiao Z; Sakumoto M; Shiozawa K; Toki S; Yoshida A; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2019 Jan; 55(1):62-73. PubMed ID: 30411273
[TBL] [Abstract][Full Text] [Related]
40. Establishment and characterization of NCC-MPNST6-C1: a novel patient-derived cell line of malignant peripheral nerve sheath tumors.
Sin Y; Yoshimatsu Y; Noguchi R; Tsuchiya R; Ono T; Akiyama T; Nakatani F; Sugaya J; Yoshida A; Kawai A; Kondo T
Hum Cell; 2022 Jan; 35(1):400-407. PubMed ID: 34775549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
